CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment, 55132 [05-18687]
Download as PDF
<![CDATA[
55132
Federal Register / Vol. 70, No. 181 / Tuesday, September 20, 2005 / Notices
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act. Additional information on all
bank holding companies may be
obtained from the National Information
Center website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than October 4, 2005.
A. Federal Reserve Bank of Cleveland
(Cindy West, Manager) 1455 East Sixth
Street, Cleveland, Ohio 44101-2566:
1. The PNC Financial Services Group,
Inc., Pittsburgh, Pennsylvania; to
acquire HW Holdings, Richmond,
Virginia, and thereby indirectly acquire
Harris Williams & Co., and Harris
Williams Advisors, Inc., and engage in
broker dealer activities and advising
clients on merger and acquisition
matters, pursuant to sections
225.28(b)(6)(iii) and (b)(7)(i) of
Regulation Y.
Board of Governors of the Federal Reserve
System, September 15, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–18695 Filed 9–19–05; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Childhood
Lead Poisoning Prevention (ACCLPP):
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the National Center for
Environmental Health (NCEH) of the
Centers for Disease Control and
Prevention (CDC) announces the
following committee meeting.
Name: Advisory Committee on Childhood
Lead Poisoning Prevention.
VerDate Aug<31>2005
17:34 Sep 19, 2005
Jkt 205001
Times and Dates: 8:30 a.m.–5:45 p.m.,
October 25, 2005. 8:30 a.m.–12:45 p.m.,
October 26, 2005.
Place: The Hubert Humphrey Federal
Building, 200 Independence Avenue, SW.,
Washington, DC 20201. Telephone: (202)
619–0100.
Status: Open to the public, limited only by
the space available. Non-federal attendees
must call Crystal Gresham prior to October
24, 2005, in order to be received as a visitor
at the Humphrey building on the day of the
meeting. The meeting room accommodates
approximately 60 people.
Purpose: The Committee provides advice
and guidance to the Secretary; the Assistant
Secretary for Health; and the Director, CDC,
regarding new scientific knowledge and
technological developments and their
practical implications for childhood lead
poisoning prevention efforts. The Committee
also reviews and reports regularly on
childhood lead poisoning prevention
practices and recommend improvements in
national childhood lead poisoning
prevention efforts.
Matters To Be Discussed: Agenda items
includes: Primary Prevention Workgroup
update; Forum on strategies for
implementation of housing-based Primary
Prevention of Lead Poisoning-federal agency
perspective; Forum-local agencies and nongovernmental organization perspective;
Washington, DC Childhood Lead Poisoning
Prevention Program; Update on the Centers
for Medicare and Medicaid Services and CDC
Policy on Targeted Screening of Medicaid
Children; update on adverse health effects of
blood lead levels <10 mg/dl—follow-up; and
update on clinical papers.
Agenda items are subject to change as
priorities dictate.
Opportunities will be provided during the
meeting for oral comments. Depending on the
time available and the number of requests, it
may be necessary to limit the time of each
presenter.
Contact Person for More Information:
Crystal M. Gresham, Management and
Program Analyst, Lead Poisoning Prevention
Branch, Division of Emergency and
Environmental Health Services, NCEH, CDC,
4770 Buford Hwy, NE., M/S F–40, Atlanta,
Georgia 30341. Telephone: (770) 488–7490,
fax: (770) 488–3635.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Name: CDC/HRSA Advisory Committee on
HIV and STD Prevention and Treatment.
Time and Date: 8 a.m.–5 p.m., October 19,
2005.
Place: Hotel Washington, 15th and
Pennsylvania Avenue, NW., Washington, DC
20004. Telephone: (202) 638–5900.
Time and Date: 8 a.m.–12 p.m., October 20,
2005.
Place: Ronald Reagan Building and
International Trade Center, Horizon Room,
1300 Pennsylvania Avenue, NW.,
Washington, DC 20004. Telephone: (202)
213–1300.
Status: Open to the public, limited only by
the space available. The meeting room will
accommodate approximately 100 people.
Purpose: This Committee is charged with
advising the Secretary; the Director, CDC;
and the Administrator, HRSA, regarding
activities related to prevention and control of
HIV/AIDS and other STDs, the support of
health care services to persons living with
HIV/AIDS, and education of health
professionals and the public about HIV/AIDS
and other STDs.
Matters To Be Discussed: Agenda items
include issues pertaining to (1) syphilis
elimination, (2) HIV Prevention Priorities for
African American Men Who Have Sex With
Men, (3) Medicare Part D Outreach/TA, and
(4) Ryan White CARE Act Reauthorization.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Paulette Ford-Knights, Public Health Analyst,
National Center for HIV, STD, and TB
Prevention, 1600 Clifton Road, NE., Mailstop
E–07, Atlanta, Georgia 30333. Telephone
(404) 639–8008, fax: (404) 639–3125, e-mail
pbf7@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: September 12, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–18690 Filed 9–19–05; 8:45 am]
Dated: September 12, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 05–18687 Filed 9–19–05; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
CDC/HRSA Advisory Committee on
HIV and STD Prevention and Treatment
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 70, Number 181 (Tuesday, September 20, 2005)]
[Notices]
[Page 55132]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-18687]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
CDC/HRSA Advisory Committee on HIV and STD Prevention and
Treatment
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting.
Name: CDC/HRSA Advisory Committee on HIV and STD Prevention and
Treatment.
Time and Date: 8 a.m.-5 p.m., October 19, 2005.
Place: Hotel Washington, 15th and Pennsylvania Avenue, NW.,
Washington, DC 20004. Telephone: (202) 638-5900.
Time and Date: 8 a.m.-12 p.m., October 20, 2005.
Place: Ronald Reagan Building and International Trade Center,
Horizon Room, 1300 Pennsylvania Avenue, NW., Washington, DC 20004.
Telephone: (202) 213-1300.
Status: Open to the public, limited only by the space available.
The meeting room will accommodate approximately 100 people.
Purpose: This Committee is charged with advising the Secretary;
the Director, CDC; and the Administrator, HRSA, regarding activities
related to prevention and control of HIV/AIDS and other STDs, the
support of health care services to persons living with HIV/AIDS, and
education of health professionals and the public about HIV/AIDS and
other STDs.
Matters To Be Discussed: Agenda items include issues pertaining
to (1) syphilis elimination, (2) HIV Prevention Priorities for
African American Men Who Have Sex With Men, (3) Medicare Part D
Outreach/TA, and (4) Ryan White CARE Act Reauthorization.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Paulette Ford-Knights,
Public Health Analyst, National Center for HIV, STD, and TB
Prevention, 1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia
30333. Telephone (404) 639-8008, fax: (404) 639-3125, e-mail
pbf7@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: September 12, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 05-18687 Filed 9-19-05; 8:45 am]
BILLING CODE 4163-18-P
